Gibson, Dunn & Crutcher LLP is advising Arrowhead Pharmaceuticals, Inc. on the offering. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced the pricing of an underwritten registered offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
